Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases

Go back to Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases
(NASDAQ: PSTV) Delayed: 3.83 +0.05 (1.32%)
Previous Close $3.78    52 Week High
Open $3.81    52 Week Low
Day High $4.00    P/E N/A 
Day Low $3.81    EPS
Volume 64,830